Depletion of RECQL4 in two glioma lines with the highest RECQL4 level and distinct genetic background (with siRNAs or the validated CRISPR/Cas9 construct) did not affect viability of LN18 cells and weakly reduced viability of LN229 cells. This evidence concerns the gene RECQL4 and glioma.